Index -
P/E -
EPS (ttm) -23.74
Insider Own 23.00%
Shs Outstand 8.26M
Perf Week 9.68%
Market Cap 22.49M
Forward P/E -
EPS next Y -1.98
Insider Trans 129.19%
Shs Float 6.37M
Perf Month -7.48%
Income -29.13M
PEG -
EPS next Q -0.67
Inst Own 85.90%
Short Float 3.66%
Perf Quarter -10.23%
Sales 1.50M
P/S 15.00
EPS this Y 36.27%
Inst Trans -33.77%
Short Ratio 3.97
Perf Half Y 18.26%
Book/sh 2.48
P/B 1.10
EPS next Y 17.29%
ROA -
Short Interest 0.23M
Perf Year -47.53%
Cash/sh 1.14
P/C 2.39
EPS next 5Y -
ROE -
52W Range 2.08 - 5.88
Perf YTD 8.80%
Dividend Est. -
P/FCF -
EPS past 5Y 14.72%
ROI -104.79%
52W High -53.76%
Beta 0.80
Dividend TTM -
Quick Ratio 1.49
Sales past 5Y 16.25%
Gross Margin -56.62%
52W Low 30.77%
ATR (14) 0.17
Dividend Ex-Date -
Current Ratio 1.49
EPS Y/Y TTM -81.28%
Oper. Margin -1482.24%
RSI (14) 51.62
Volatility 7.95% 6.87%
Employees 46
Debt/Eq 0.11
Sales Y/Y TTM -
Profit Margin -1938.06%
Recom 1.67
Target Price 4.42
Option/Short No / Yes
LT Debt/Eq 0.09
EPS Q/Q -21.67%
Payout -
Rel Volume 0.30
Prev Close 2.78
Sales Surprise 39.56%
EPS Surprise -224.29%
Sales Q/Q -69.12%
Earnings Apr 12 BMO
Avg Volume 58.77K
Price 2.72
SMA20 2.81%
SMA50 -4.74%
SMA200 -14.03%
Trades
Volume 13,295
Change -2.14%
Date
Action
Analyst
Rating Change
Price Target Change
May-24-22 Downgrade
Stephens
Overweight → Equal-Weight
Mar-14-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jan-07-22 Initiated
Stephens
Overweight
$3.10
Jan-06-22 Resumed
Piper Sandler
Overweight
$3.10
Mar-17-21 Resumed
Needham
Buy
$8
Jan-07-21 Upgrade
The Benchmark Company
Speculative Buy → Buy
$6
Dec-16-20 Upgrade
Piper Sandler
Neutral → Overweight
$2 → $4
Nov-30-20 Initiated
BTIG Research
Buy
$5
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$5
Jul-30-20 Reiterated
The Benchmark Company
Speculative Buy
$7 → $6
Jul-01-20 Downgrade
Piper Sandler
Overweight → Neutral
Jun-30-20 Downgrade
Chardan Capital Markets
Buy → Neutral
$2
Jun-02-20 Initiated
Needham
Buy
$4
Feb-13-19 Initiated
Piper Jaffray
Overweight
$6
Jan-29-19 Upgrade
Janney
Neutral → Buy
Dec-19-18 Resumed
Lake Street
Buy
Show Previous Ratings
Apr-12-24 10:52AM
06:00AM
Apr-11-24 09:46PM
05:30PM
Apr-09-24 04:05PM
08:00AM
Loading…
Jan-16-24 08:00AM
Dec-06-23 08:00AM
Nov-09-23 08:27AM
07:00AM
Nov-03-23 08:30AM
Sep-18-23 08:00AM
Sep-06-23 08:00AM
Aug-28-23 08:30AM
Aug-10-23 07:00AM
Aug-09-23 08:00AM
08:30AM
Loading…
Aug-08-23 08:30AM
Aug-03-23 08:00AM
Jul-25-23 09:08AM
Jul-24-23 01:35PM
Jun-27-23 08:30AM
Jun-01-23 04:15PM
May-11-23 08:00AM
Apr-27-23 04:59PM
Apr-18-23 08:45AM
Apr-12-23 04:15PM
Apr-07-23 08:24AM
Apr-03-23 08:00AM
Mar-31-23 05:00PM
Mar-29-23 04:01PM
Mar-15-23 04:01PM
09:00AM
Loading…
Mar-02-23 09:00AM
Feb-22-23 08:00AM
Dec-16-22 08:19AM
08:00AM
Nov-30-22 06:05PM
06:00PM
Nov-10-22 04:30PM
Oct-27-22 04:01PM
Oct-06-22 08:00AM
Sep-07-22 08:00AM
Aug-31-22 04:01PM
Aug-30-22 04:27PM
Aug-24-22 08:00AM
Aug-10-22 04:05PM
Aug-03-22 04:01PM
Aug-01-22 11:33AM
05:00AM
Jul-27-22 04:01PM
Jul-13-22 08:00AM
Jul-06-22 08:00AM
Jun-22-22 08:00AM
Jun-15-22 07:15AM
May-26-22 05:00PM
May-11-22 04:05PM
May-05-22 08:00AM
Apr-28-22 04:01PM
Apr-27-22 04:30PM
Apr-22-22 09:26AM
Apr-13-22 10:01PM
05:12PM
05:10PM
Apr-11-22 08:00AM
Mar-28-22 08:00AM
Mar-10-22 04:05PM
Mar-01-22 04:05PM
Feb-21-22 07:26AM
Feb-10-22 08:00AM
Jan-18-22 04:05PM
Jan-06-22 09:43AM
Jan-04-22 08:00AM
Dec-09-21 06:00PM
Dec-08-21 08:00AM
Dec-06-21 08:00AM
Dec-02-21 08:00AM
Nov-22-21 06:14AM
Nov-09-21 04:05PM
Nov-04-21 08:00AM
Nov-02-21 03:02PM
Oct-27-21 08:00AM
Oct-26-21 04:05PM
Oct-08-21 09:46AM
Oct-07-21 08:00AM
Sep-30-21 08:00AM
Sep-20-21 11:35AM
08:00AM
Sep-16-21 08:00AM
Sep-13-21 08:00AM
Sep-07-21 04:05PM
Aug-23-21 09:13AM
Aug-18-21 08:49AM
Aug-17-21 08:00AM
Aug-10-21 04:01PM
Aug-09-21 08:00AM
Aug-03-21 03:00PM
Jul-27-21 10:35AM
Jul-08-21 05:34AM
Jun-22-21 08:00AM
Jun-15-21 08:03AM
Jun-03-21 08:00AM
Jun-01-21 08:00AM
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BROADWOOD PARTNERS, L.P. 10% Owner Apr 11 '24 Buy 2.92 2,420,000 7,057,688 4,929,066 Apr 15 07:21 PM Arno Andrew Director Apr 11 '24 Buy 2.95 33,898 99,999 69,054 Apr 15 06:02 AM Riggs Josh CEO and President Apr 11 '24 Buy 2.95 3,390 10,000 3,505 Apr 15 06:04 AM KINGSLEY ALFRED D Director Jun 14 '23 Buy 0.21 30,000 6,447 469,111 Jun 15 08:13 PM
Index -
P/E -
EPS (ttm) -119.99
Insider Own 23.17%
Shs Outstand 5.60M
Perf Week -2.89%
Market Cap 9.41M
Forward P/E -
EPS next Y -15.20
Insider Trans 18.22%
Shs Float 4.31M
Perf Month 13.51%
Income -150.76M
PEG -
EPS next Q -5.28
Inst Own 6.22%
Short Float 12.06%
Perf Quarter -41.24%
Sales 70.56M
P/S 0.13
EPS this Y 82.97%
Inst Trans -
Short Ratio 0.34
Perf Half Y -75.71%
Book/sh -3.09
P/B -
EPS next Y 23.39%
ROA -187.84%
Short Interest 0.52M
Perf Year -99.05%
Cash/sh 0.37
P/C 4.57
EPS next 5Y -
ROE -304.94%
52W Range 1.45 - 180.91
Perf YTD -43.61%
Dividend Est. -
P/FCF -
EPS past 5Y -49.91%
ROI -11200.97%
52W High -99.07%
Beta 1.51
Dividend TTM -
Quick Ratio 0.48
Sales past 5Y 5.41%
Gross Margin -21.66%
52W Low 15.86%
ATR (14) 0.25
Dividend Ex-Date -
Current Ratio 0.65
EPS Y/Y TTM -65.40%
Oper. Margin -117.24%
RSI (14) 46.14
Volatility 10.41% 20.01%
Employees 64
Debt/Eq -
Sales Y/Y TTM 13.60%
Profit Margin -213.68%
Recom 2.00
Target Price 53.28
Option/Short No / Yes
LT Debt/Eq -
EPS Q/Q 37.36%
Payout -
Rel Volume 0.10
Prev Close 1.68
Sales Surprise -56.99%
EPS Surprise -106.78%
Sales Q/Q -61.69%
Earnings Mar 28 BMO
Avg Volume 1.52M
Price 1.68
SMA20 -6.72%
SMA50 -16.49%
SMA200 -85.59%
Trades
Volume 107,667
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-21-22 Initiated
Alliance Global Partners
Buy
$5
Jun-15-22 Initiated
Craig Hallum
Buy
$5
Mar-08-22 Initiated
ROTH Capital
Buy
$6
Jul-23-21 Initiated
Cowen
Outperform
$5
Oct-16-17 Reiterated
Chardan Capital Markets
Buy
$3.50 → $11.50
Aug-11-16 Reiterated
Chardan Capital Markets
Buy
$4.50 → $3.50
Apr-30-24 09:00AM
Apr-29-24 09:00AM
Apr-18-24 05:00PM
09:00AM
Apr-15-24 09:00AM
04:45PM
Loading…
Apr-11-24 04:45PM
Apr-08-24 09:25AM
09:01AM
Apr-05-24 02:52PM
Apr-04-24 05:48PM
Apr-01-24 02:59PM
Mar-28-24 12:53PM
06:00AM
Mar-15-24 08:00AM
Feb-13-24 04:15PM
07:00AM
Loading…
Feb-07-24 07:00AM
Feb-06-24 11:00AM
Feb-05-24 07:29AM
Jan-24-24 04:15PM
Jan-17-24 08:45AM
Jan-12-24 08:30AM
Dec-28-23 04:20PM
Dec-14-23 04:05PM
Dec-04-23 07:07AM
Nov-29-23 07:07AM
Nov-27-23 04:44PM
Nov-08-23 01:15PM
Nov-07-23 08:45AM
Nov-06-23 08:16AM
07:30AM
05:17PM
Loading…
Oct-29-23 05:17PM
Oct-26-23 08:30AM
Oct-25-23 09:00AM
Oct-17-23 09:15AM
Oct-16-23 04:05PM
Sep-12-23 07:00AM
Sep-05-23 07:00AM
07:00AM
Aug-17-23 09:39AM
Aug-14-23 06:00AM
Aug-09-23 08:00AM
Aug-08-23 07:00AM
Aug-07-23 08:00AM
Jul-31-23 08:57AM
Jul-24-23 10:47AM
09:20AM
Jul-20-23 09:20AM
Jul-17-23 09:20AM
Jul-13-23 09:40AM
08:40AM
Jul-12-23 08:35AM
Jul-06-23 09:25AM
Jul-03-23 06:00AM
Jun-23-23 09:00AM
Jun-21-23 09:00AM
Jun-20-23 07:00AM
Jun-06-23 09:00AM
Jun-02-23 08:30AM
May-25-23 09:00AM
May-09-23 06:00AM
May-03-23 09:15AM
May-02-23 09:15AM
Apr-18-23 07:00AM
Apr-05-23 08:30AM
Mar-09-23 06:00AM
Mar-03-23 04:05PM
Mar-02-23 04:15PM
Feb-23-23 09:00AM
Feb-22-23 09:00AM
Feb-07-23 09:00AM
Jan-24-23 09:20AM
Jan-23-23 09:33PM
09:20AM
Jan-18-23 09:25AM
Jan-17-23 09:00AM
Dec-16-22 08:05AM
Dec-13-22 09:25AM
Dec-08-22 01:00PM
Nov-21-22 04:10PM
Nov-17-22 06:00AM
(American City Business Journals) +5.69%
Nov-16-22 09:25AM
Nov-15-22 09:25AM
Nov-14-22 08:19AM
Nov-08-22 06:00AM
Nov-07-22 09:43AM
Oct-27-22 09:15AM
Oct-26-22 09:25AM
Oct-18-22 09:20AM
Oct-06-22 04:05PM
09:30AM
Oct-03-22 09:25AM
Sep-20-22 09:25AM
Sep-13-22 09:30AM
Sep-12-22 04:05PM
Sep-07-22 04:45PM
09:00AM
Aug-24-22 09:27AM
Aug-22-22 09:30AM
Aug-09-22 06:00AM
Jul-27-22 07:00AM
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Arno Andrew Director Jan 05 '24 Buy 0.17 100,000 17,490 100,000 Jan 08 08:04 PM FIRESTONE LAWRENCE Chief Executive Officer Jan 04 '24 Buy 0.17 100,000 17,360 100,000 Jan 05 04:32 PM
Index -
P/E -
EPS (ttm) -2.97
Insider Own 11.03%
Shs Outstand 9.35M
Perf Week 2.59%
Market Cap 22.85M
Forward P/E 1.98
EPS next Y 1.20
Insider Trans -4.52%
Shs Float 8.54M
Perf Month -4.62%
Income -24.40M
PEG -
EPS next Q -0.40
Inst Own 12.95%
Short Float 1.76%
Perf Quarter -65.30%
Sales 40.86M
P/S 0.56
EPS this Y -50.00%
Inst Trans -
Short Ratio 0.92
Perf Half Y -71.12%
Book/sh 8.06
P/B 0.30
EPS next Y 225.00%
ROA -25.79%
Short Interest 0.15M
Perf Year -74.57%
Cash/sh 0.74
P/C 3.21
EPS next 5Y 10.75%
ROE -32.15%
52W Range 1.88 - 14.96
Perf YTD -63.98%
Dividend Est. -
P/FCF -
EPS past 5Y -21.69%
ROI -31.61%
52W High -84.09%
Beta 0.73
Dividend TTM -
Quick Ratio 2.21
Sales past 5Y 12.88%
Gross Margin 56.18%
52W Low 26.43%
ATR (14) 0.25
Dividend Ex-Date -
Current Ratio 2.21
EPS Y/Y TTM 29.88%
Oper. Margin -43.81%
RSI (14) 46.78
Volatility 10.13% 11.71%
Employees 231
Debt/Eq 0.04
Sales Y/Y TTM -15.77%
Profit Margin -59.70%
Recom 1.00
Target Price 16.50
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q 35.13%
Payout -
Rel Volume 0.74
Prev Close 2.30
Sales Surprise -2.83%
EPS Surprise -3.83%
Sales Q/Q -24.66%
Earnings May 08 AMC
Avg Volume 163.98K
Price 2.38
SMA20 6.23%
SMA50 -13.50%
SMA200 -65.77%
Trades
Volume 89,586
Change 3.48%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-29-22 Initiated
The Benchmark Company
Buy
$5
Aug-05-21 Initiated
Dawson James
Buy
$11.10
Apr-27-21 Initiated
The Benchmark Company
Buy
$9
Oct-19-20 Initiated
Lake Street
Buy
$7
Jul-19-19 Initiated
B. Riley FBR
Buy
$5
Oct-19-15 Downgrade
Needham
Buy → Hold
Feb-25-15 Upgrade
Needham
Hold → Buy
$2.10
Jan-07-15 Upgrade
H.C. Wainwright
Neutral → Buy
$2
Jul-18-14 Initiated
H.C. Wainwright
Neutral
May-05-11 Downgrade
Needham
Buy → Hold
Apr-20-11 Downgrade
Wedbush
Outperform → Neutral
$12 → $9
Feb-09-11 Downgrade
Northland Securities
Outperform → Market Perform
$17 → $10
Feb-09-11 Downgrade
Brigantine
Buy → Hold
Jan-25-11 Initiated
Dougherty & Company
Neutral
$12
Dec-10-10 Reiterated
Wedbush
Outperform
$16 → $19
Nov-12-10 Reiterated
Northland Securities
Outperform
$15 → $17
Nov-10-10 Initiated
Brigantine
Buy
$18
Nov-04-10 Reiterated
Wedbush
Outperform
$13 → $16
Nov-04-10 Reiterated
Northland Securities
Outperform
$13 → $15
May-12-10 Upgrade
Wedbush
Neutral → Outperform
$11 → $12.50
Show Previous Ratings
May-01-24 04:56PM
Apr-30-24 11:56AM
09:15AM
Apr-05-24 11:51AM
Apr-03-24 04:15PM
07:00AM
Loading…
Apr-02-24 07:00AM
Feb-23-24 10:23AM
06:52AM
(Thomson Reuters StreetEvents)
Feb-22-24 04:10PM
04:05PM
Feb-15-24 04:15PM
Jan-30-24 03:15PM
Jan-11-24 09:15AM
Dec-05-23 09:15AM
Nov-09-23 10:40AM
09:17AM
Loading…
09:17AM
(Thomson Reuters StreetEvents)
Nov-08-23 04:05PM
Nov-07-23 09:15AM
Oct-31-23 04:05PM
Oct-20-23 12:28PM
Sep-17-23 10:54AM
Aug-30-23 09:15AM
Aug-09-23 06:15PM
04:05PM
Aug-01-23 04:05PM
Jul-13-23 11:42AM
Jul-11-23 09:56AM
May-11-23 05:55PM
04:05PM
May-04-23 09:15AM
09:15AM
Loading…
Apr-28-23 09:15AM
Mar-29-23 09:15AM
Mar-15-23 03:18AM
Mar-13-23 02:55AM
Mar-10-23 06:53AM
05:59AM
(Thomson Reuters StreetEvents)
Mar-09-23 06:35PM
04:05PM
Mar-06-23 09:35AM
Mar-02-23 04:05PM
Mar-01-23 04:21PM
Feb-27-23 01:02PM
09:15AM
Feb-21-23 09:15AM
Feb-12-23 04:17PM
Feb-01-23 08:12AM
Jan-17-23 09:15AM
Nov-29-22 09:15AM
Nov-28-22 09:15AM
Nov-12-22 07:18AM
Nov-09-22 08:51PM
07:45PM
04:47PM
Nov-02-22 04:05PM
Aug-12-22 11:27AM
02:31AM
Aug-11-22 06:15PM
04:05PM
04:05PM
01:27PM
06:31AM
Aug-04-22 04:05PM
Jul-19-22 09:19AM
Jun-13-22 06:27AM
Jun-10-22 10:23AM
May-11-22 01:35PM
May-04-22 09:30PM
05:25PM
04:01PM
04:01PM
May-02-22 04:05PM
Apr-27-22 04:05PM
Apr-25-22 05:35PM
Apr-12-22 08:30AM
Apr-05-22 08:30AM
Mar-30-22 09:31AM
Mar-10-22 10:00PM
04:12PM
Mar-04-22 05:35AM
Mar-03-22 04:40PM
Mar-02-22 06:15PM
Feb-23-22 06:05PM
Feb-07-22 08:38PM
Dec-09-21 12:15AM
Nov-11-21 12:00PM
Nov-10-21 04:05PM
Nov-05-21 02:24PM
Oct-27-21 03:03PM
08:00AM
Oct-06-21 08:00AM
Sep-29-21 08:00AM
Sep-28-21 05:11AM
Aug-12-21 04:05PM
Aug-07-21 04:11AM
Aug-04-21 06:45PM
04:05PM
Jul-28-21 04:05PM
03:03PM
Jul-20-21 04:05PM
Jul-16-21 06:02AM
Smith Micro Software, Inc. engages in the provision of software solutions. It offers wireless internet solutions which enable access to information and entertainment. Its products include SafePath Family, SafePath IoT, SafePath Home, CommSuite VVM, CommSuite VTT, and ViewSpot. The company was founded by William W. Smith Jr. on November 30, 1982 and is headquartered in Pittsburgh, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SMITH WILLIAM W JR President & CEO Mar 13 '24 Sale 0.35 11,651 4,078 673,262 Mar 15 04:33 PM Kempton James M VP, CFO and Treasurer Mar 13 '24 Sale 0.35 4,804 1,681 407,973 Mar 15 04:34 PM SMITH WILLIAM W JR President & CEO Jan 23 '24 Sale 0.77 6,952 5,319 353,559 Jan 24 04:34 PM Kempton James M VP, CFO and Treasurer Jan 23 '24 Sale 0.77 2,293 1,754 234,664 Jan 24 04:36 PM SMITH WILLIAM W JR President & CEO Dec 01 '23 Sale 0.67 17,660 11,832 439,168 Dec 01 06:11 PM Kempton James M VP, CFO and Treasurer Dec 01 '23 Sale 0.67 6,780 4,543 238,830 Dec 01 06:09 PM Kempton James M VP, CFO and Treasurer Jun 14 '23 Buy 1.19 1,000 1,190 204,719 Jun 15 04:58 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite